Connection
Lisa Brents to Cannabinoid Receptor Agonists
This is a "connection" page, showing publications Lisa Brents has written about Cannabinoid Receptor Agonists.
|
|
Connection Strength |
|
![](https://uams-triprofiles.uams.edu/profiles/Framework/Images/connection_left.gif) |
|
![](https://uams-triprofiles.uams.edu/profiles/Framework/Images/connection_right.gif) |
|
0.103 |
|
|
|
-
Seely KA, Brents LK, Franks LN, Rajasekaran M, Zimmerman SM, Fantegrossi WE, Prather PL. AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies. Neuropharmacology. 2012 Oct; 63(5):905-15.
Score: 0.103